Celgene Corp. is acquiring Pharmion Corp. for $2.9 billion in a cash and stock deal that will expand the Summit, N.J.-based biotech's presence in the global hematology and oncology markets. (BioWorld Today)
Celgene Corp. is acquiring Pharmion Corp. for $2.9 billion in a cash and stock deal that will expand the Summit, N.J.-based biotech's presence in the global hematology and oncology markets. (BioWorld Today)
In an effort to boost its vaccine and biological development pipeline, Pfizer Inc. is acquiring Coley Pharmaceutical Group Inc. in a deal worth about $164 million. (BioWorld Today)
In an effort to boost its vaccine and biological development pipeline, Pfizer Inc. is acquiring Coley Pharmaceutical Group Inc. in a deal worth about $164 million. (BioWorld Today)
Advanced Life Sciences Holdings Inc. is proceeding with its new drug application (NDA) for cethromycin in community-acquired pneumonia (CAP) after results of the second of two pivotal clinical trials showed that the ketolide antibiotic met its primary endpoint of statistical noninferiority cure rates. (BioWorld Today)
Advanced Life Sciences Holdings Inc. is proceeding with its new drug application (NDA) for cethromycin in community-acquired pneumonia (CAP) after results of the second of two pivotal clinical trials showed that the ketolide antibiotic met its primary endpoint of statistical noninferiority cure rates. (BioWorld Today)
A week after losing a major partnership, Nastech Pharmaceutical Co. Inc. said it plans to lay off up to 75 workers in an attempt to cut costs. (BioWorld Today)
A week after losing a major partnership, Nastech Pharmaceutical Co. Inc. said it plans to lay off up to 75 workers in an attempt to cut costs. (BioWorld Today)
